ADDvise Group signs LOI to acquire CliniChain Holding

ADDvise Group AB has signed a Letter of Intent to acquire 100% of CliniChain Holding B.V., a medtech equipment provider for clinical studies based in Almere, Netherlands. The purchase price is EUR 33.80 million, with completion scheduled for Q4 2022.

“ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of CliniChain Holding B.V. regarding an acquisition of 100 percent of the shares in CliniChain.”news.cision.com

• 1 source
• news.cision.comADDvise signs Letter of Intent to acquire CliniChain Holding B.V. - ADDvise Group ABSep 6, 2022

Summarized from public sources; check the original articles before acting on it.